TransCode Therapeutics Reports 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 4.13 +0.17 (4.29%)
Previous Close $3.96    52 Week High
Open $3.91    52 Week Low
Day High $4.26    P/E N/A 
Day Low $3.91    EPS
Volume 10,970